Sept 27, 2019, Guangzhou, China—BeiGene, Ltd, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced the Phase 1 completion of its Guangzhou Bio-manufacturing Base.
China Unicom (Guangdong) Industrial Internet Corporation was incorporated as an independent legal entity in SSGKC, with registered capital of 100 million yuan.
The first bio-material fast clearance platform in South China and the third after Beijing Zhongguancun and Shanghai Zhangjiang, the platform has an integrated inspection area, a cold chain supervision library at three customs levels, and a government office area, performing the four custom functions of declaration, quarantine inspection, warehousing and logistics, and collection and trade.
Guangzhou Regenerative Medicine and Health Guangdong Laboratory is one of the first of four provincial laboratories approved by the provincial government and targeted to become a national laboratory.
The project is intended to set up the freight logistics headquarter platform of China Southern Airlines in SSGKC, integrating the upstream and downstream supply chain of logistics services in a more efficiently collaborative manner.
Guangding Mining Group owns the world's first "easily selected and easy to access" large-scale independent rubidium (Rb) mine for mining and utilization approved by the state.
Greatoo Intelligent Equipment Industrial Park in SSGKC is funded by Greatoo Intelligent Equipment Inc., with a total investment of about 1.5 billion yuan and an output value of about 4 billion yuan during operation.
General Electric (GE) BioPark is a creation of GE Healthcare headed by GE, a Global 500 company, with a total investment of US $400 million.